We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

APR Acquires Drug Delivery Nanotechnology Platform Providing Treatments for Critical Diseases

News   Feb 24, 2009

 
APR Acquires Drug Delivery Nanotechnology Platform Providing Treatments for Critical Diseases
 
 
 

RELATED ARTICLES

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Compact Spectrometer Opens New Doors in Portable Analysis

News

A compact infrared spectrometer has been developed that's small enough to fit on a computer chip but can still open up interesting possibilities – in space and in everyday life.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE